Grand Pharmaceutical Group Limited — M&A Activity 2018

Sep 10, 2018

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [146 x 42] intentionally omitted <==

China Grand Pharmaceutical and Healthcare Holdings Limited 遠大醫藥健康控股有限公司 *

(Incorporated in Bermuda with limited liability) (Stock Code: 00512)

PROGRESS UPDATE IN RELATION TO ACQUISITION OF THE ENTIRE ISSUED SHARE CAPITAL OF SIRTEX MEDICAL LIMITED

Reference is made to the announcement of China Grand Pharmaceutical and Healthcare Holdings Limited dated 14 June 2018, and the circular dated 26 July 2018 (the “ Circular ”) in relation to, among other things, the acquisition of Sirtex Medical Limited. Terms used herein shall have the same meanings as those defined in the Circular unless otherwise stated.

The Board is pleased to announce that, as announced by Sirtex today, the resolution to approve the Scheme was passed by the requisite majorities of the Sirtex Shareholders at the Scheme Meeting held on 10 September 2018, being a majority in number (more than 50%) of the Sirtex Shareholders present and voting at the Scheme Meeting and at least 75% of the total number of votes cast on the resolution at the Scheme Meeting.

The Company and CDH Genetech had deposited all Scheme Consideration into an escrow account as contemplated by the Scheme Implementation Deed before the Scheme Meeting was held.

Furthermore, as required by the Australian laws, Sirtex has applied to the Court to approve the Scheme at a hearing scheduled on 12 September 2018. Subject to the Court’s approval and the fulfillment of all conditions precedent of the Scheme Implementation Deed, the Acquisition is expected to be completed on 20 September 2018.

The Company will make further announcement following any material development of the Acquisition.

By order of the Board China Grand Pharmaceutical and Healthcare Holdings Limited Liu Chengwei Chairman

Hong Kong, 10 September, 2018

1

As at the date of this announcement, the Board comprises four executive directors, namely, Mr Liu Chengwei, Mr Hu Bo, Dr Shao Yan and Dr Niu Zhanqi and two independent non-executive directors, namely, Ms So Tosi Wan, Winnie and Dr Pei Geng.

* For identification purpose only

2